Breast Cancer News and Research

Latest Breast Cancer News and Research

UArizona researchers working on a less toxic treatment for deadly breast cancer

After decades of research and two previous drug development attempts, things are looking promising for a team of University of Arizona researchers working on a less toxic treatment for a specific type of breast cancer.

25 Oct 2022

New evidence on how intermittent fasting impacts women's reproductive hormones

Intermittent fasting has been shown to be an effective way to lose weight, but critics have worried that the practice may have a negative impact on women's reproductive hormones.

25 Oct 2022

Researchers set sights on a new therapeutic target for aggressive breast cancer

Researchers at VCU Massey Cancer Center have set their sights on a new therapeutic target for an aggressive form of breast cancer with limited treatment options.

25 Oct 2022

Study reconsiders the recommended age for screening women with family history of breast cancer

A new study released in the American Cancer Society journal Cancer reconsiders guidelines for when to start screening with mammograms if a woman has a mother, sister, or daughter who was diagnosed with breast cancer.

21 Oct 2022

Cedars Sinai experts remind men of their breast cancer risk

Although breast cancer is more common in women, during October, Breast Cancer Awareness Month, experts from Cedars-Sinai Cancer are reminding men that they are at risk as well. One in every 100 breast cancers in the U.S. is diagnosed in a man, according to the Centers for Disease Control and Prevention.

21 Oct 2022

Mayo Clinic scientists awarded $12.1 million NCI grant for breast cancer research

A team of researchers from Mayo Clinic Comprehensive Cancer Center has been awarded a five-year, $12.1 million Specialized Program of Research Excellence (SPORE) grant in breast cancer from the National Cancer Institute.

20 Oct 2022

Study develops a strategy to noninvasively track tumor-associated macrophages

A Ludwig Cancer Research study has developed a strategy to noninvasively track immune cells known as macrophages within brain and breast tumors in living mice.

19 Oct 2022

Salk's three collaborative projects win 2022 Curebound Discovery Grant

The Salk Institute's American Cancer Society Professor Tony Hunter, Professor Reuben Shaw, and Assistant Professor Graham McVicker are among 12 inaugural 2022 Discovery Grant winners.

19 Oct 2022

Hair straightening chemicals linked to uterine cancer risk

A new study in the Journal of the National Cancer Institute aimed to analyze the association of hair product use with age-specific uterine cancer in a large, ethnically, and racially diverse population in the United States.

18 Oct 2022

Penn State researchers lay the foundation for precision fabrication of tumor models

Researchers at Penn State have successfully 3D bioprinted breast cancer tumors and treated them in a breakthrough study to better understand the disease that is one of the leading causes of mortality worldwide.

18 Oct 2022

Physical exercise improves cardiorespiratory fitness, alleviates adverse effects of cancer treatment

During chemotherapy, physical exercise intervention is safe, improves long-term cardiorespiratory fitness, and alleviates some of the adverse effects of cancer treatment, according to a study published in JACC: CardioOncology.

18 Oct 2022

Extra time spent in the EHR may benefit certain care outcomes, study suggests

In the United States, the electronic health record (EHR) has become increasingly prevalent in the day-to-day practice of physicians, with primary care physicians (PCPs) spending the most time in the EHR.

18 Oct 2022

Survey measures common myths and misconceptions about breast reconstruction surgery

As many as 50 percent of cancer patients who've undergone a mastectomy have elected to have breast reconstruction surgery.

17 Oct 2022

Novel drug target for triple-negative breast cancer discovered

Research led by Dr. Suresh Alahari, Professor of Biochemistry at LSU Health New Orleans' Schools of Medicine and Graduate Studies, reports a combination of a novel small inhibitory molecule and an FDA-approved chemotherapy drug suppresses the growth of triple-negative breast cancer cells synergistically.

17 Oct 2022

Women using chemical hair straightening products at higher risk for uterine cancer

Women who used chemical hair straightening products were at higher risk for uterine cancer compared to women who did not report using these products, according to a new study from the National Institutes of Health.

17 Oct 2022

After Congress fails to add dental coverage, Medicare weighs limited benefit expansion

Proposed changes in Medicare rules could soon pave the way for a significant expansion in Medicare-covered dental services, while falling short of the comprehensive benefits that many Democratic lawmakers have advocated.

17 Oct 2022

Study determines how fibroblasts play a role in tumor's ability to generate anti-HER2 therapy resistance

A study led by researchers at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) has determined the role that fibroblasts, the cells that contribute to tissue formation, play in a tumor's ability to generate resistance to the most common biological treatment for HER2.

14 Oct 2022

Multi-center analysis shines light on invasive lobular carcinoma

A multi-center analysis of patients with invasive lobular carcinoma, or ILC -; the second most common histological subtype of invasive breast cancer in the U.S. -; showed that, despite its prevalence, ILC is detected later and has worse outcomes than the predominant subtype of invasive breast cancer, known as invasive ductal carcinoma (IDC), or no special type.

14 Oct 2022

Over £800 million to support improved healthcare delivery and breakthroughs in new treatments

Patients up and down the country are set to benefit from innovative new treatments and improved delivery of health and care services following significant funding to support ground-breaking experimental medicine research and advance the UK's response to patient safety challenges.

14 Oct 2022

Two new studies help improve the understanding of ovarian cancer

Two new discoveries led by Cedars-Sinai Cancer investigators help improve the understanding of what drives the development of ovarian cancer and why some women's tumors do not respond to therapy.

11 Oct 2022

Breast Cancer News and Research

Latest Breast Cancer News and Research

UArizona researchers working on a less toxic treatment for deadly breast cancer

New evidence on how intermittent fasting impacts women's reproductive hormones

Researchers set sights on a new therapeutic target for aggressive breast cancer

Study reconsiders the recommended age for screening women with family history of breast cancer

Cedars Sinai experts remind men of their breast cancer risk

Mayo Clinic scientists awarded $12.1 million NCI grant for breast cancer research

Study develops a strategy to noninvasively track tumor-associated macrophages

Salk's three collaborative projects win 2022 Curebound Discovery Grant

Hair straightening chemicals linked to uterine cancer risk

Penn State researchers lay the foundation for precision fabrication of tumor models

Physical exercise improves cardiorespiratory fitness, alleviates adverse effects of cancer treatment

Extra time spent in the EHR may benefit certain care outcomes, study suggests

Survey measures common myths and misconceptions about breast reconstruction surgery

Novel drug target for triple-negative breast cancer discovered

Women using chemical hair straightening products at higher risk for uterine cancer

After Congress fails to add dental coverage, Medicare weighs limited benefit expansion

Study determines how fibroblasts play a role in tumor's ability to generate anti-HER2 therapy resistance

Multi-center analysis shines light on invasive lobular carcinoma

Over £800 million to support improved healthcare delivery and breakthroughs in new treatments

Two new studies help improve the understanding of ovarian cancer

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Breast Cancer News and Research

Latest Breast Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in